Skip to content

The effect of intravenous metoclopramide on gastric emptying

Evaluation of the effect of intravenous metoclopramide on gastric emptying in drug-using patients based on ultrasound criteria

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20210406050864N1
Enrollment
135
Registered
2021-11-07
Start date
2021-09-18
Completion date
Unknown
Last updated
2021-11-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Effect of methoclopramide on gastric motility.

Interventions

Intervention 1: Intervention group: will include patients taking opium with a BMI less than 35. Who have consumed solid food in the last 8 hours or consumed clear liquids in the last 2 hours. After ob

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 80 Years

Inclusion criteria

Inclusion criteria: All patients referred to the emergency department between the age of 16 and 80years All patients referred to the emergency department with BMI less than 35 All patients referred to the emergency department with history of opium use All patients who had consumed solid food in the past 8 hours or liquids in the previous 2 hours in the intervention group

Exclusion criteria

Exclusion criteria: Patients who are unable to have an ultrasound for any reason Patients with a history of diabetes Patients with a history of gastrointestinal surgery Patients with suspected gastrointestinal obstruction Patients taking medication that affects gastrointestinal motility Patients with a history of inflammatory bowel disease Patients with a history of irritable bowel disease

Design outcomes

Primary

MeasureTime frame
Gastric emptying. Timepoint: 30min. Method of measurement: sonographic criteria.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohamad javad Yazdipoor

Shahid Beheshti University of Medical Sciences

Mjyazdipooor@gmail.com+98 21 7443 2380

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026